These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37531179)

  • 1. Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC-MS-Based Metabolomic Approaches.
    Qin X; Wang Y; MacKenzie KR; Hakenjos JM; Chen S; Khalil SM; Jung SY; Young DW; Guo L; Li F
    Chem Res Toxicol; 2023 Aug; 36(8):1427-1438. PubMed ID: 37531179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.
    Towles JK; Clark RN; Wahlin MD; Uttamsingh V; Rettie AE; Jackson KD
    Drug Metab Dispos; 2016 Oct; 44(10):1584-97. PubMed ID: 27450182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of luteolin in primary rat hepatocytes: the role of CYP3A-mediated ortho-benzoquinone metabolite formation and glutathione depletion.
    Shi F; Zhao P; Li X; Pan H; Ma S; Ding L
    J Appl Toxicol; 2015 Nov; 35(11):1372-80. PubMed ID: 25612170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism.
    Liu X; Lu Y; Guan X; Dong B; Chavan H; Wang J; Zhang Y; Krishnamurthy P; Li F
    Biochem Pharmacol; 2015 Sep; 97(1):111-21. PubMed ID: 26212543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of the relationship between evodiamine-induced liver injury and CYP3A4-mediated metabolic activation by UPLC-MS/MS analysis.
    Peng T; Rao J; Zhang T; Wang Y; Li N; Gao Q; Feng X; Song Z; Wang K; Qiu F
    Anal Bioanal Chem; 2023 Sep; 415(23):5619-5635. PubMed ID: 37433953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation.
    Bissada JE; Truong V; Abouda AA; Wines KJ; Crouch RD; Jackson KD
    Drug Metab Dispos; 2019 Nov; 47(11):1257-1269. PubMed ID: 31492693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity.
    Shen Q; Zuo M; Ma L; Tian Y; Wang L; Jiang H; Zhou Q; Zhou H; Yu L; Zeng S
    Chem Biol Interact; 2014 Dec; 224():89-99. PubMed ID: 25451576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
    Amaya GM; Durandis R; Bourgeois DS; Perkins JA; Abouda AA; Wines KJ; Mohamud M; Starks SA; Daniels RN; Jackson KD
    Chem Res Toxicol; 2018 Jul; 31(7):570-584. PubMed ID: 29847931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Activation of Pesticide Isoprocarb Mediated by CYP3A4 and the Possible Correlation with Its Cytotoxicity.
    Guan C; Zhao G; Sun C; Zhang M; Liu S; Jiang Z; Li W; Peng Y; Zheng J
    J Agric Food Chem; 2023 Feb; 71(5):2390-2398. PubMed ID: 36706223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A-mediated generation of aldehyde and hydrazine in atazanavir metabolism.
    Li F; Lu J; Wang L; Ma X
    Drug Metab Dispos; 2011 Mar; 39(3):394-401. PubMed ID: 21148252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP3A4 on liver injury induced by triptolide.
    Xiao X; Zhang T; Huang J; Zhao Q; Li F
    Biomed Chromatogr; 2020 Aug; 34(8):e4864. PubMed ID: 32330997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects.
    Zahir H; Greenberg J; Shuster D; Hsu C; Watanabe K; LaCreta F
    Clin Pharmacokinet; 2022 Nov; 61(11):1623-1639. PubMed ID: 36264536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.
    Jiang LL; Jiang Y; Zhao DS; Fan YX; Yu Q; Li P; Li HJ
    Chem Res Toxicol; 2018 Oct; 31(10):1052-1060. PubMed ID: 30203651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic proļ¬ling of tyrosine kinase inhibitor nintedanib using metabolomics.
    Zhou ZM; Wang YK; Yan DM; Fang JH; Xiao XR; Zhang T; Cheng Y; Xu KP; Li F
    J Pharm Biomed Anal; 2020 Feb; 180():113045. PubMed ID: 31887668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iminium ion metabolites are formed from nintedanib by human CYP3A4.
    Nakashima S; Fukami T; Kudo T; Nakano M; Matsui A; Ishiguro N; Nakajima M
    Drug Metab Pharmacokinet; 2024 Aug; 57():101025. PubMed ID: 39068856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Chen Y; Fitch WL
    Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Pathways in Idelalisib Metabolism and Bioactivation.
    Zhu J; Wang P; Shehu AI; Lu J; Bi H; Ma X
    Chem Res Toxicol; 2018 Jul; 31(7):548-555. PubMed ID: 29896955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
    Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
    Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
    Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
    Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A
    Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.